Shandong Xinhua Pharmaceutical Company Limited (HKG: 0719)

Shandong Xinhua Pharmaceutical Company Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,158	918.33	1,159	744.66	855.77	690.47
Cash & Short-Term Investments	1,158	918.33	1,159	744.66	855.77	690.47
Cash Growth	40.52%	-20.75%	55.61%	-12.98%	23.94%	-12.18%
Accounts Receivable	1,089	949.16	970.63	870.46	518.55	455.23
Other Receivables	12.32	9.65	12.65	17.42	25.16	19.68
Receivables	1,102	958.81	983.28	887.87	543.71	474.91
Inventory	1,265	1,313	1,212	1,028	1,124	1,130
Prepaid Expenses	-	-	-	-	7.15	4.44
Other Current Assets	104.21	124.2	102.95	93.88	155.88	128.23
Total Current Assets	3,630	3,314	3,457	2,754	2,687	2,428
Property, Plant & Equipment	4,221	4,061	4,000	3,766	3,539	3,201
Long-Term Investments	330.12	241.37	239.18	260.2	316.62	296.25
Other Intangible Assets	497.96	494.94	474.11	466.45	449.25	411.59
Long-Term Deferred Tax Assets	15.96	23.48	15.62	15.17	23.52	26.01
Long-Term Deferred Charges	11.12	14.46	8.61	10.54	11.92	-
Other Long-Term Assets	118.94	136.77	69.85	59.99	65.93	72.81
Total Assets	8,824	8,286	8,265	7,332	7,093	6,436
Accounts Payable	1,107	1,178	1,090	1,066	742.9	798.51
Accrued Expenses	44.56	203.11	159.43	122.35	144.87	112.39
Short-Term Debt	569.5	283.96	118.02	269.46	200.42	540
Current Portion of Long-Term Debt	296.2	271.97	714.77	421.03	356.55	289.66
Current Portion of Leases	-	1.78	2.69	2.8	1.56	59.34
Current Income Taxes Payable	30.39	5.03	7.99	12.2	4.42	5.72
Current Unearned Revenue	85.91	149.14	593.26	100.4	377.79	364.95
Other Current Liabilities	570.07	393.16	472.23	507.26	552.53	314.95
Total Current Liabilities	2,704	2,486	3,158	2,502	2,381	2,486
Long-Term Debt	791.04	799.4	545.66	946.2	1,063	589.78
Long-Term Leases	0.39	1.58	2.72	6.77	23.93	51.14
Long-Term Unearned Revenue	88.03	100.67	118.37	133.97	146.5	141.67
Long-Term Deferred Tax Liabilities	120.27	99.21	66.44	65.61	69.31	53.82
Other Long-Term Liabilities	25.06	23.56	23.56	26.46	18.14	3.56
Total Liabilities	3,728	3,510	3,915	3,681	3,702	3,325
Common Stock	682.41	674.68	669.63	627.37	621.86	621.86
Additional Paid-In Capital	1,131	1,055	998.14	677.94	644.91	634.14
Retained Earnings	2,863	2,706	2,345	2,034	1,780	1,530
Comprehensive Income & Other	195.12	117.01	113.68	128.37	177.21	183.45
Total Common Equity	4,871	4,553	4,126	3,468	3,224	2,969
Minority Interest	224.6	222.65	223.29	183.2	167.5	141.5
Shareholders' Equity	5,096	4,776	4,350	3,651	3,391	3,111
Total Liabilities & Equity	8,824	8,286	8,265	7,332	7,093	6,436
Total Debt	1,657	1,359	1,384	1,646	1,645	1,530
Net Cash (Debt)	-498.81	-440.36	-225.11	-901.58	-789.42	-839.45
Net Cash Per Share	-0.72	-0.64	-0.34	-1.44	-1.26	-1.35
Filing Date Shares Outstanding	682.41	682.41	669.63	627.37	627.37	621.86
Total Common Shares Outstanding	682.41	674.68	669.63	627.37	621.86	621.86
Working Capital	926	828.33	298.47	252.08	305.83	-57.13
Book Value Per Share	7.14	6.75	6.16	5.53	5.18	4.77
Tangible Book Value	4,373	4,058	3,652	3,001	2,775	2,557
Tangible Book Value Per Share	6.41	6.01	5.45	4.78	4.46	4.11
Buildings	-	2,271	2,244	2,078	1,948	1,777
Machinery	-	4,703	4,468	4,011	3,690	3,265
Construction In Progress	-	730.55	545.89	562.96	416.99	392.14

Source: S&P Capital IQ. Standard template. Financial Sources.